Hemophilia A: all 885 studies
Page 5 of 9. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.
- A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)CompletedNCT06144086Phase 2
- Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion ProteinCompletedNCT06142552Phase 3
- rFVIII-Fc (Produced by AryoGen Pharmed Co.) Pharmacokinetic StudyCompletedNCT06137092Phase 3
- Study of TU7710 in Warfarin Anti-coagulated Healthy Male SubjectsCompletedNCT06025552Phase 1
- Genetic Factors of the Desmopressin Response in Carriers of Hemophilia ACompletedNCT06020456
- SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand TreatmentCompletedNCT06010953Phase 1/2
- A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia AActive, not recruitingNCT05911763
- Trial of an Exercise Intervention for Children With HaemophiliaCompletedNCT05895032Not applicable
- Reliability and Validity of the Turkish Version of the PedHALStatus unknownNCT05889754
- Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With HemophiliaCompletedNCT05879549Not applicable
- A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)CompletedNCT05878938Phase 3
- A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog AlfaCompletedNCT05817812Phase 3
- Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in HemophiliaCompletedNCT05804734
- A Study of SerpinPC in Participants with Hemophilia B (HemB) with InhibitorsTerminatedNCT05789537Phase 2
- The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia BTerminatedNCT05789524Phase 2
- Emotions in the Communication and Relationship Styles of Parents With Hemophilic Children.Status unknownNCT05754619
- Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia ACompletedNCT05752565Not applicable
- Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA PatientsCompletedNCT05728528Phase 4
- Baby Detect : Genomic Newborn ScreeningCompletedNCT05687474
- A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia AActive, not recruitingNCT05685238Phase 3
- A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and CartridgeCompletedNCT05681845Phase 1
- A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe HemophiliaActive, not recruitingNCT05662319Phase 3
- A Phase I of SS109 in Hemophilia A or and B With InhibitorsCompletedNCT05651061Phase 1
- An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A.Active, not recruitingNCT05643560
- Neutrophil-to-lymphocyte and Platelet-to-lymphocyte Ratio in Predicting the Incidence of Nausea and VomitingStatus unknownNCT05636163
- Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia AStatus unknownNCT05628558
- An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine EsperoctCompletedNCT05621746
- Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without InhibitorCompletedNCT05619926Phase 2
- In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia PatientsCompletedNCT05617209
- He-move-philia, Lifestyle Intervention for Patients With HemophiliaActive, not recruitingNCT05608863Not applicable
- Gaining Insight Into the Complexity of Pain in Patients With HaemophiliaCompletedNCT05606640
- Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5)TerminatedNCT05605678
- Clinical, Functional and Musculoskeletal Differences Between Adult Patients With Hemophilia and Their Healthy PeersStatus unknownNCT05589662
- A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)TerminatedNCT05580692Not applicable
- Resistance Training With Blood Flow Restriction in HemophiliaCompletedNCT05568524Not applicable
- Vitamin D Deficiency and Body Composition in the Patients With HemophiliaCompletedNCT05517070
- A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia PatientCompletedNCT05493631Phase 1
- Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With InhibitorStatus unknownNCT05487976Phase 3
- Satisfaction Regarding the Dispensing of Emicizumab (HEMLIBRA®) for Patients With Haemophilia A in FranceCompletedNCT05450640
- Evaluation of the Training Program for Community Pharmacists for Dispensing Emicizumab (HEMLIBRA®) in FranceCompletedNCT05449197
- Lead-in Study of VGB-R04 Gene Therapy for Hemophilia B-- An Observational Survey Analysis StudyStatus unknownNCT05442528
- A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B PatientsStatus unknownNCT05441553Phase 1/2
- Validation and Reliability of the CHO-KLAT in TurkishStatus unknownNCT05439642Not applicable
- KN057 Multiple Dose Study in Moderately Severe to Severe HemophiliaCompletedNCT05421429Phase 2
- A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment CentersTerminatedNCT05395858
- Learning to Live With Non-severe HaemophiliaCompletedNCT05314751
- Factor IX as Adjunctive Therapy to Emicizumab (EMIX)CompletedNCT05281718Early Phase 1
- Clinical Outcomes of Low Dose PK-guided EHL FVIII Concentrates Versus Standard Prophylaxis in Severe Haemophilia ACompletedNCT05281185Phase 4
- Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory CoastCompletedNCT05279924Not applicable
- Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia ACompletedNCT05265767Phase 1
- A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionCompletedNCT05265286Phase 2
- A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for InjectionCompletedNCT05251090Phase 1
- Real World Use of Emicizumab in Infants and Children Ages 0-3 Years With Hemophilia ACompletedNCT05248594
- Are There Differences Between Carriers of Haemophilia A and B?CompletedNCT05217992
- Chronic Pain and HemophiliaActive, not recruitingNCT05202951
- Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic ArthropathyStatus unknownNCT05187936
- A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab ProphylaxisActive, not recruitingNCT05181618Phase 4
- Posture Analysis for Patients With HaemophiliaCompletedNCT05173129Not applicable
- Prevalence of Autistic Spectrum Disorder (ASD) in Children With HaemophiliaCompletedNCT05138224
- A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsActive, not recruitingNCT05135559Phase 3
- Bone Microarchitecture in Men With HemophiliaTerminatedNCT05127681Not applicable
- A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy PeopleCompletedNCT05127473Phase 1
- Observatory of Patients With Haemophilia B Treated by IdElvion®Active, not recruitingNCT05086575
- A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without InhibitorsCompletedNCT05053139Phase 3
- Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia ACompletedNCT05042440Phase 1
- A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With InhibitorCompletedNCT05027230Phase 1/2
- A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia ACompletedNCT04953000
- Effects of Progressive Resistance Training Compared With Aerobic Training in Patients With HemophiliaCompletedNCT04892628Not applicable
- A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to AdynovateCompletedNCT04876365
- A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for InjectionCompletedNCT04864743Phase 1
- Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active ConditionsStatus unknownNCT04845555
- Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia ACompletedNCT04845399Phase 3
- Safety and Efficacy in a ReAl-Life Study in Patients With Haemophilia Treated wIth NovoEight® for SurgeryCompletedNCT04808349
- The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII InhibitorsStatus unknownNCT04805801
- Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor CellsCompletedNCT04805021
- Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With InhibitorsCompletedNCT04789954Early Phase 1
- Intensive Replacement Treatment in Haemophilia Patients With SynovitisCompletedNCT04784988Phase 4
- Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation DeficienciesStatus unknownNCT04775888
- Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.Status unknownNCT04768699Phase 1
- Effect of Exercise in Pediatric HemophiliaStatus unknownNCT04754997Not applicable
- A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With InhibitorCompletedNCT04747964Phase 1
- Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)CompletedNCT04731701
- Health Related Quality of Life of Youth and Young Adults With Haemophilia ACompletedNCT04728217Phase 4
- An Exploration of the Impact of Gene Therapy on the Lives of People With Haemophilia and Their FamiliesCompletedNCT04723680
- Pain and Joint Status With Psychosocial Factors in Patients With HemophiliaStatus unknownNCT04715100
- The Effects of Exercise Training in Children With HemophiliaCompletedNCT04703062Not applicable
- POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement TherapiesWithdrawnNCT04690322Phase 4
- Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.CompletedNCT04688034Phase 1
- Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsCompletedNCT04684940Phase 1/2
- BT200 in Hereditary Bleeding DisordersCompletedNCT04677803Phase 2
- Register of Patients With haEmophilia A tReated With Afstyla®CompletedNCT04675541
- Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AActive, not recruitingNCT04644575Phase 3
- Preventing Inhibitor Recurrence IndefinitelyActive, not recruitingNCT04621916Phase 4
- Observational Study of Long-Term Joint Health Outcome in Hemophilia PatientStatus unknownNCT04618237
- A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLipStatus unknownNCT04592692Phase 2
- Pulsed Electromagentic Field in HaemophiliaStatus unknownNCT04590456Not applicable
- iT-based Sports Therapy Application in HaemophiliaCompletedNCT04586101Not applicable
- Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational ActivitiesCompletedNCT04584892
- Clinical and Health-related Outcome of rFVIIIFc ProphylaxisStatus unknownNCT04583930
- TFPI Levels in Haemophilia A and B PatientsStatus unknownNCT04570696